Matthew J. Cowcher
Lawyers

Advises on a broad range of public and private transactions, including mergers, acquisitions, investments, spinoffs and joint ventures.
Matthew advises on a broad range of public and private transactions, including mergers, acquisitions, investments, spinoffs, joint ventures and other corporate partnering arrangements, and other general corporate matters. His experience includes a wide variety of U.S. and international transactions across a number of industries, including technology, financial services, media and communications, consumer products, biotech, pharmaceuticals and cryptoassets.
Experience highlights
Recent Representations
- ProKidney combination with Social Capital Suvretta Holdings Corp. III
- MoneyLion acquisition of Even Financial
- Virgin Acquisition Corp. II $1.5 billion combination with Grove Collaborative
- Digicel Group $1.85 billion sale of Pacific operations to Telstra
- Lightyear Capital partners with Schellman & Company
- Taboola $800 million acquisition of Connexity
- Clarivate $5.3 billion acquisition of ProQuest
- Charles River Laboratories $875 million acquisition of Cognate
- 23andMe $3.5 billion merger with Virgin Group’s VG Acquisition
- IHS Markit joint venture with CME Group
- Novo Nordisk acquisition of Emisphere Technologies
- Bristol Myers Squibb acquisition of Forbius
- Novo Nordisk $725 million acquisition of Corvidia Therapeutics
- EdgeMarc Energy reaches global settlement including sale of assets to KB OREO
- Schwab $26 billion acquisition of TD Ameritrade
- Davis Polk Advises NBC Sports on Its Acquisition of EZLinks Golf
Education
LL.B., University of Western Australia
- first-class honours
Professional history
- Counsel, 2022-present
- Associate, 2016-2021
Qualifications and admissions
- State of New York